← Back to Screener
Tevogen Bio Holdings Inc. Common Stock (TVGN)
Price$9.06
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-73.63%
Price vs S&P 500 (4W)9.98%
VGM Score25.72
Market Capitalization$35.47M
All Metrics
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$0.12
Price vs S&P 500 (YTD)-60.21%
EPS (TTM)$-6.79
10-Day Avg Trading Volume0.04M
EPS Excl Extra (TTM)$-6.79
EPS (Annual)$-7.91
Cash / Share (Quarterly)$0.17
ROA (Last FY)-599.49%
EBITD / Share (TTM)$-6.45
Cash Flow / Share (Annual)$-3.08
Net Income / Employee (Annual)$-1,459,700
Net Interest Coverage (TTM)-133.32x
ROA (TTM)-472.79%
EPS Incl Extra (Annual)$-7.91
Current Ratio (Annual)0.22x
Quick Ratio (Quarterly)0.12x
3-Month Avg Trading Volume0.03M
52-Week Price Return-86.87%
Revenue / Employee (TTM)$0
52-Week High$75.50
EPS Excl Extra (Annual)$-7.91
26-Week Price Return-60.05%
Quick Ratio (Annual)0.10x
13-Week Price Return-31.97%
Current Ratio (Quarterly)0.29x
Enterprise Value$42.83M
Revenue / Employee (Annual)$0
Cash / Share (Annual)$0.14
3-Month Return Std Dev159.02%
Net Income / Employee (TTM)$-1,186,400
Net Interest Coverage (Annual)-87.17x
EPS Basic Excl Extra (Annual)$-7.91
Receivables Turnover (TTM)0.00x
EV / Free Cash Flow (TTM)84.00x
EPS Incl Extra (TTM)$-6.79
Revenue / Share (Annual)$0.00
Price vs S&P 500 (52W)-115.02%
Year-to-Date Return-48.82%
5-Day Price Return17.80%
EPS Normalized (Annual)$-7.91
ROA (5Y Avg)-296.98%
Month-to-Date Return7.08%
EBITD / Share (Annual)$-7.82
P/CF (TTM)61.76x
EPS Basic Excl Extra (TTM)$-6.79
Price vs S&P 500 (13W)-42.63%
Beta0.22x
Revenue / Share (TTM)$0.00
52-Week Low$4.13
mGradeD
vgmGradeD
Show chart for
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.14
4.14
2.17
2.17
Industry Peers — Biological Products(178)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
TVGNTevogen Bio Holdings Inc. Common Stock | — | — | D | $9.06 |
| AMGNAmgen Inc | C | C | C | $338.22 |
| GILDGilead Sciences Inc | C | B | C | $128.99 |
| ARGXargenx SE American Depositary Shares | D | A | B | $813.14 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $155.99 |
| BIIBBiogen Inc. Common Stock | B | D | C | $195.96 |
| BNTXBioNTech SE American Depositary Share | C | C | D | $88.45 |
| MRNAModerna, Inc. Common Stock | C | B | C | $49.06 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $165.11 |
| EXELExelixis Inc | C | B | B | $51.60 |
| KRYSKrystal Biotech, Inc. Common Stock | D | B | B | $301.82 |
About
Tevogen Bio Holdings is a clinical-stage immunotherapy company developing off-the-shelf T cell therapies. The company harnesses CD8+ cytotoxic T lymphocytes to create precision treatments for infectious diseases, cancers, and neurological disorders. Its platform is designed for broad use without requiring patient-specific customization.